Boguski Named to Science Magazine Board
Dr. Mark Boguski,
a senior investigator in the Computational
Biology Branch of NLM's National Center for Biotechnology
Information and an intramural researcher at NIH for 12 years, has
agreed to join Science magazine's board of reviewing editors.
Editor-in-chief Dr. Floyd Bloom said Boguski is not only widely
respected in his own field but also has the breadth to evaluate
science outside his own area. "The outside world looks to this blue
ribbon group for their competence and fairness," he said. Boguski's
1-year term began in January, and is renewable by mutual consent
for 4 years. He has written and lectured extensively on
bioinformatics and genomics, and developed the first publicly
available database system for expression array data. His current
research interests include the analysis of data from large-scale
expression studies and pharmacogenomics. He is an organizer of the
Cold Spring Harbor Symposium on Genome Sequencing and
Biology and has served on grant review and advisory panels for a
number of government and private funding agencies and as a
consultant to industry. Boguski holds an adjunct faculty position in
the department of molecular biology and genetics at Johns Hopkins
University School of Medicine and is a former editor of the journal
Genome Research.
Hicks Joins CSR
Dr. Nancy Hicks
recently joined the Center for Scientific Review as
a scientific review administrator in the social sciences, nursing,
epidemiology, and methods integrated review group. She served
some 12 years as a commissioned officer in the Public Health
Service Commissioned Corps, assigned as an epidemiologist to the
Centers for Disease Control, the Oak Ridge Associated Universities
and the Food and Drug Administration. In 1990, she was an
environmental consultant in epidemiology to the WHO, where she
provided scientific expertise to the United Arab Emirates, Ethiopia
and Kenya. Hicks has specialized in studies of the health effects of
ionizing radiation, elemental mercury and beryllium as well as on
epidemiological and statistical methods, and has published
extensively.
Huebner Named NIAAA Division Deputy Director
Dr. Robert Huebner
has been named deputy director of NIAAA's
Division of Clinical and Prevention Research. He will be responsible
for advising the DCPR director in planning, administering and
implementing alcohol treatment, prevention and health services
research programs. In 1988, Huebner joined NIAAA and for the
next 6 years directed the national evaluation of NIAAA's multi-site
research demonstration programs on homelessness. In 1994, he was
named chief of the Health Services Research Program where he led
the development of NIAAA's health services research portfolio,
oversaw completion of a strategic plan for health services research,
and was active in a number of trans-NIH committees on managed
care. Before joining NIAAA, he conducted research on health issues
in the GAO's program evaluation and methodology division.
McNicol To Direct NEI Extramural Research Division
Dr. Loré Anne McNicol
was recently appointed director of NEI's
Division of Extramural Research. She joined NEI in 1989 as the
Corneal Diseases Program director. Since then, she has worn many
hats within NEI: director of the Lens and Cataract Program; chief of
the Anterior Segment Diseases Branch; director of the Division of
Extramural Activities; and most recently director of the Vision
Research Program. She received her Ph.D. in medical sciences from
Boston University School of Medicine, performing her thesis work
on the structure of virulence antigens of Salmonella typhosa. She
later did postdoctoral work in bacteriophage genetics at Tufts
University School of Medicine. In 1983, McNicol joined the malaria
unit of NIAID, before starting her administrative career in 1985 at
NIGMS.
GMS Council Gains Four
NIGMS director Dr. Marvin Cassman (c) recently welcomed four
new members to the National Advisory General Medical Sciences
Council. They are (from l): Dr. Richard M. Weinshilboum,
professor of pharmacology and medicine at the Mayo Medical
School, whose research interests center on pharmacogenetics; Dr.
Jay C. Dunlap, chair of the newly created department of genetics at
Dartmouth Medical School, whose research interests include the
molecular mechanisms of biological clocks; Dr. D. Amy Trainor,
global product director, CNS (central nervous system), at
AstraZeneca Pharmaceuticals, where she leads the development of
new drugs for the treatment of neurodegenerative and psychiatric
disorders; and Dr. John N. Abelson, George Beadle professor of
biology at the California Institute of Technology, whose research
focuses on the mechanism of RNA splicing.
Up to Top